{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:51:29Z","timestamp":1791557489826,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec><jats:title>Abstract<\/jats:title><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>National studies reporting the prevalence of cannabis use have focused on individuals with a history of cancer without distinction by their treatment status, which can impact symptom burden. While pain is a primary motivation to use cannabis in cancer, the magnitude of its association with cannabis use remains understudied.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We examined cannabis use and pain management among 5523 respondents of the Behavioral Risk Factor Surveillance System with a cancer history. Survey-weighted prevalence proportions of respondents\u2019 cannabis use are reported, stratified on cancer treatment status. Regression models estimated odds ratios (ORs) and 95% confidence intervals (CIs) of cancer-related pain and cannabis use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Cannabis use was slightly more prevalent in those undergoing active treatment relative to those who were not undergoing active treatment (9.3% vs. 6.2%;<jats:italic>P<\/jats:italic>=0.05). Those under active treatment were more likely to use cannabis medicinally (71.6% vs. 50.0%;<jats:italic>P<\/jats:italic>=0.03). Relative to those without cancer-related pain, persons with pain under medical control (OR 2.1, 95% CI, 1.4\u20133.2) or uncontrolled pain were twice as likely to use cannabis (OR 2.0, 95% CI, 1.1\u20133.5).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Use of cannabis among cancer patients may be related to their treatment and is positively associated with cancer-related pain. Future research should investigate the associations of cannabis use, symptom burden, and treatment regimens across the treatment spectrum to facilitate interventions.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s00520-024-08321-9","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T07:02:22Z","timestamp":1705561342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Current cannabis use and pain management among US cancer patients"],"prefix":"10.1007","volume":"32","author":[{"given":"Jessica L.","family":"Krok-Schoen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse J.","family":"Plascak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Strassels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Adib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neema C.","family":"Adley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore L.","family":"Wagener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore M.","family":"Brasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"8321_CR1","volume-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, DSDUG Series H-56)","author":"Substance Abuse and Mental Health Services Administration","year":"2021","unstructured":"Substance Abuse and Mental Health Services Administration (2021) Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, DSDUG Series H-56). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD"},{"issue":"9","key":"8321_CR2","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1158\/2767-9764.CRC-23-0233","volume":"3","author":"TM Brasky","year":"2023","unstructured":"Brasky TM, Newton AM, Conroy S et al (2023) Marijuana and cannabidiol use prevalence and symptom management among cancer patients. Cancer Res Commun 3(9):1917\u20131926","journal-title":"Cancer Res Commun"},{"issue":"58","key":"8321_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/jncimonographs\/lgab012","volume":"2021","author":"IM Braun","year":"2021","unstructured":"Braun IM, Abrams DI, Blansky SE et al (2021) Cannabis and the Cancer Patient. JNCI Monographs 2021(58):68\u201377","journal-title":"JNCI Monographs"},{"key":"8321_CR4","doi-asserted-by":"crossref","unstructured":"Sarkar S, Braun IM, Nayak M et al (2023) Cannabis use among cancer survivors before and during the COVID-19 pandemic, 2019-2021. JNCI Cancer Spectr 7(3):pkad031","DOI":"10.1093\/jncics\/pkad031"},{"issue":"16","key":"8321_CR5","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/cncr.34793","volume":"129","author":"AE Sedani","year":"2023","unstructured":"Sedani AE, Campbell JE, Beebe LA (2023) Cannabis use among cancer survivors in 22 states: results from the Behavioral Risk Factor Surveillance System, 2020. Cancer 129(16):2499\u20132513","journal-title":"Cancer"},{"issue":"13","key":"8321_CR6","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/cncr.32059","volume":"125","author":"KR Tringale","year":"2019","unstructured":"Tringale KR, Huynh-Le MP, Salans M et al (2019) The role of cancer in marijuana and prescription opioid use in the United States: a population-based analysis from 2005 to 2014. Cancer 125(13):2242\u20132251","journal-title":"Cancer"},{"issue":"4","key":"8321_CR7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s11764-021-01138-z","volume":"17","author":"M Lee","year":"2023","unstructured":"Lee M, Salloum RG, Jenkins W et al (2023) Marijuana use among US adults with cancer: findings from the 2018\u20132019 Behavioral Risk Factor Surveillance System. J Cancer Surviv 17(4):1161\u20131170","journal-title":"J Cancer Surviv"},{"issue":"21","key":"8321_CR8","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1002\/cncr.33794","volume":"127","author":"EK Do","year":"2021","unstructured":"Do EK, Ksinan AJ, Kim SJ et al (2021) Cannabis use among cancer survivors in the United States: analysis of a nationally representative sample. Cancer 127(21):4040\u20134049","journal-title":"Cancer"},{"issue":"18","key":"8321_CR9","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1002\/cncr.33646","volume":"127","author":"MM Cousins","year":"2021","unstructured":"Cousins MM, Jannausch ML, Coughlin LN et al (2021) Prevalence of cannabis use among individuals with a history of cancer in the United States. Cancer 127(18):3437\u20133444","journal-title":"Cancer"},{"issue":"2","key":"8321_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.prro.2022.11.002","volume":"13","author":"MM Cousins","year":"2023","unstructured":"Cousins MM, Mayo C, Devasia T et al (2023) Cannabis use in patients seen in an academic radiation oncology department. Pract Radiat Oncol 13(2):112\u2013121","journal-title":"Pract Radiat Oncol"},{"issue":"8","key":"8321_CR11","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1089\/jpm.2022.0199","volume":"25","author":"PS Bramati","year":"2022","unstructured":"Bramati PS, Cadavid A, Bansal A et al (2022) Letter to the editor: prevalence of self-reported cannabis use among patients at a supportive care clinic in a tertiary cancer center. J Palliat Med 25(8):1176\u20131178","journal-title":"J Palliat Med"},{"issue":"9","key":"8321_CR12","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/COC.0000000000000718","volume":"43","author":"DM Macari","year":"2020","unstructured":"Macari DM, Gbadamosi B, Jaiyesimi I et al (2020) Medical cannabis in cancer patients: a survey of a community hematology oncology population. Am J Clin Oncol 43(9):636\u2013639","journal-title":"Am J Clin Oncol"},{"issue":"9","key":"8321_CR13","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.1200\/JOP.18.00057","volume":"14","author":"CE Saadeh","year":"2018","unstructured":"Saadeh CE, Rustem DR (2018) Medical marijuana use in a community cancer center. J Oncol Pract 14(9):e566\u2013e578","journal-title":"J Oncol Pract"},{"issue":"22","key":"8321_CR14","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1002\/cncr.30879","volume":"123","author":"SA Pergam","year":"2017","unstructured":"Pergam SA, Woodfield MC, Lee CM et al (2017) Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer 123(22):4488\u20134497","journal-title":"Cancer"},{"issue":"12","key":"8321_CR15","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s10552-021-01468-4","volume":"32","author":"PA Newcomb","year":"2021","unstructured":"Newcomb PA, Ton M, Malen RC et al (2021) Cannabis use is associated with patient and clinical factors in a population-based sample of colorectal cancer survivors. Cancer Causes Control: CCC 32(12):1321\u20131327","journal-title":"Cancer Causes Control: CCC"},{"issue":"7","key":"8321_CR16","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00520-023-07881-6","volume":"31","author":"EA McClure","year":"2023","unstructured":"McClure EA, Walters KJ, Tomko RL et al (2023) Cannabis use prevalence, patterns, and reasons for use among patients with cancer and survivors in a state without legal cannabis access. Support Care Cancer 31(7):429","journal-title":"Support Care Cancer"},{"key":"8321_CR17","unstructured":"Centers for Disease Control and Prevention (2013) The BRFSS Data User Guide. https:\/\/www.cdc.gov\/brfss\/data_documentation\/pdf\/UserguideJune2013.pdf.\u00a0Accessed\u00a022 Sep 2023"},{"key":"8321_CR18","doi-asserted-by":"publisher","unstructured":"Cleeland CS (2007) Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr. https:\/\/doi.org\/10.1093\/jncimonographs\/lgm005(37):16-21","DOI":"10.1093\/jncimonographs\/lgm005(37):16-21"},{"key":"8321_CR19","doi-asserted-by":"crossref","unstructured":"Aviram J, Lewitus GM, Vysotski Y et al (2022) The effectiveness and safety of medical cannabis for treating cancer related symptoms in oncology patients. Front Pain Res:3","DOI":"10.3389\/fpain.2022.861037"},{"issue":"Suppl 1","key":"8321_CR20","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1097\/j.pain.0000000000001929","volume":"162","author":"E Fisher","year":"2021","unstructured":"Fisher E, Moore RA, Fogarty AE et al (2021) Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain 162(Suppl 1):S45\u2013s66","journal-title":"Pain"},{"key":"8321_CR21","doi-asserted-by":"publisher","first-page":"175883591986636","DOI":"10.1177\/1758835919866362","volume":"11","author":"AS Kleckner","year":"2019","unstructured":"Kleckner AS, Kleckner IR, Kamen CS et al (2019) Opportunities for cannabis in supportive care in cancer. Ther Adv Med Oncol 11:1758835919866362","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"8321_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","volume":"39","author":"JR Johnson","year":"2010","unstructured":"Johnson JR, Burnell-Nugent M, Lossignol D et al (2010) Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symp Manag 39(2):167\u2013179","journal-title":"J Pain Symp Manag"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08321-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08321-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08321-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T08:05:13Z","timestamp":1731053113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08321-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["8321"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08321-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"3 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"111"}}